Papers Published
Abstract:
A study proposed to see the effectiveness of a collagen type I synthesis inhibitor, Tempostatin [trademark] (Halofuginone), at inhibiting collagen deposition around implanted materials was discussed. The data indicated that halofuginone was effective at inhibiting the deposition of collagen within the capsule that formed around the implanted silicone. It was also indicated that halofuginone inhibited collagen synthesis by inhibiting TGF-β activity. The presence of TGF-beta in the peri-implant space suggested that halofuginone treatment may be an effective method for minimizing fibrous capsule formation around implants.
Keywords:
Fibers;Implants (surgical);Enzyme inhibition;Synthesis (chemical);Colorimetry;Blood;Chromophores;Morphology;